Physician profile
Jorge Gonzalez
NPI 1821172032
$114,123.64
in general payments reported to CMS, 2019-2025
12 companies · $333 in 2025
The $333 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64K · 2020: $20K · 2021: $11K · 2022: $13K · 2023: $4,449 · 2024: $1,807 · 2025: $333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,780 · Food and Beverage: $808.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,780.00 |
| Food and Beverage | $808.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $101,127.58 | 2019-2023 | Xarelto |
| Merck Sharp & Dohme LLC | $7,110.95 | 2021-2024 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $3,214.47 | 2021-2022 | |
| Medtronic Vascular, INC. | $756.56 | 2019 | |
| Medtronic, INC. | $533.69 | 2019-2025 | Symplicity G3 |
| Novartis Pharmaceuticals Corporation | $416.85 | 2019-2020 | |
| Abbott Laboratories | $280.46 | 2024 | Aveir, Jot Dx, Gallant |
| Boston Scientific Corporation | $215.08 | 2019-2025 | Watchman Flx |
| Amgen INC. | $168.17 | 2019-2025 | Repatha |
| Astrazeneca Pharmaceuticals Lp | $119.10 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $94.49 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $86.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jorge Gonzalez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.